)
Edge28 Nov 2025
Keeping the Streak Alive: The Story of Duolingo
How Duolingo made language learning addictive, scaled to millions of users, and built a powerful subscription business around everyday practice.
Dyadic International (DYAI) investor relations material
Dyadic International Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary12 Nov, 2025
Executive summary
Transitioned from R&D to a commercial biotech focus, rebranding as Dyadic Applied BioSolutions in August 2025 and launching a new website to enhance commercial and investor engagement.
Added CRISPR Cas9 gene editing via ERS Genomics license, enhancing strain optimization and productivity.
Expanded global reach through partnerships, especially in Asia-Pacific (Japan, Korea), targeting biopharma and cell therapy markets.
Achieved key milestones in life sciences, food, nutrition, and legacy collaborations, including Gates Foundation and CEPI grants.
Received first commercial bulk protein sales and purchase orders in cell culture media and molecular biology reagent segments.
Financial highlights
Q3 2025 total revenue was $1,165,000, down from $1,958,000 year-over-year; nine-month revenue was $2.52 million, down from $2.68 million year-over-year.
Net loss for Q3 2025 increased to $1,976,000 ($0.06/share) from $203,000 ($0.01/share) year-over-year; nine-month net loss widened to $5.80 million from $4.26 million.
Cash, cash equivalents, and investment-grade securities totaled $10.4 million as of September 30, 2025, up from $9.3 million at year-end 2024.
Closed a public offering in August 2025, raising $4.9 million net for working capital and product development.
Gross margin impacted by lower milestone revenue, higher cost of grant revenue, and increased R&D expenses.
Outlook and guidance
Anticipates growth in product revenue in Life Sciences and Food & Nutrition for the remainder of 2025, with commercial launches of animal-free serum albumin and enzymes expected late 2025 or early 2026.
Existing liquidity of $10.4 million expected to cover operational needs for at least the next 12 months.
Ongoing losses and negative cash flows anticipated as commercialization continues; additional capital may be sought if needed.
Focused on accelerating product sales, expanding global customer engagement, and advancing commercialization in core segments.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Dyadic International earnings date
IAccess Alpha Virtual MicroCap Conference9 Dec, 2025
Next Dyadic International earnings date
IAccess Alpha Virtual MicroCap Conference9 Dec, 2025
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Dyadic International Inc. is a biotechnology company specializing in the development and commercialization of technologies for gene expression and protein production. The company’s primary platform, the C1 gene expression system, is used to produce enzymes and proteins for various industries, including biopharmaceuticals, vaccines, and industrial applications. Dyadic focuses on leveraging its proprietary technology to accelerate the development of biologics and other biotechnological products, aiming to improve production efficiency and scalability. The company is headquartered in Jupiter, Florida, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage